Table:
|  | 2019 | 2018 |
| --- | --- | --- |
| Revenues |  |  |
| FEI-NY | 76.9% | 68.4% |
| FEI-Zyfer | 24.7 | 38.8 |
| Less intersegment revenues | (1.6) | (7.2) |
|  | 100.0 | 100.0 |
| Cost of Revenues | 68.1 | 86.9 |
| Gross profit | 31.9 | 13.1 |
| Selling and Administrative expenses | 24.5 | 26.9 |
| Research and Development expenses | 13.1 | 17.6 |
| Operating Profit/(Loss) | (5.7) | (31.4) |
| Other Income (Expenses), net | 0.7 | 2.8 |
| Provision (Benefit) for Income Taxes | 0.1 | 28.4 |
| Loss from continuing operations | (5.1) | (57.0) |
| (Loss) Income from discontinued operations, net of tax | - | (2.5) |
| Loss on sale of discontinued operations | - | (0.9) |
| Net Loss | (5.1)% | (60.4)% |
Paragraphs:
Consolidated Results
The table below sets forth for the fiscal years ended April 30, 2019 and 2018, the percentage of consolidated net sales represented by certain items in the Company’s consolidated statements of operations:
Question:
What does the table show?
Answer: for the fiscal years ended April 30, 2019 and 2018, the percentage of consolidated net sales represented by certain items in the Company’s consolidated statements of operations